Wall Street Associates’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.21M Sell
112,000
-65,500
-37% -$873K 0.8% 41
2016
Q3
$2.9M Hold
177,500
0.99% 28
2016
Q2
$1.69M Buy
177,500
+35,100
+25% +$382K 0.68% 61
2016
Q1
$2M Buy
142,400
+25,900
+22% +$268K 0.83% 40
2015
Q4
$1.26M Buy
+116,500
New +$1.05M 0.36% 101

Other funds holding NPTN

Wall Street Associates's NPTN Position: Q4 2016 in Review

Wall Street Associates reduced its NEOPHOTONICS CORP (NPTN) stake by 37% in Q4 2016, selling an estimated $873K and leaving 112,000 shares worth $1.21M. The position accounts for 0.8% of the portfolio, ranked #41.

Wall Street Associates first reported a position in NPTN in Q4 2015 and has held it in 5 quarters since. The position peaked at $2.9M in Q3 2016. 127 funds tracked by Wall St. Rank hold NPTN as of Q4 2016.

  • Wall Street Associates held 112,000 shares of NEOPHOTONICS CORP worth $1.21M as of Q4 2016.
  • Wall Street Associates sold 65,500 NEOPHOTONICS CORP shares in Q4 2016, an estimated $873K.
  • NEOPHOTONICS CORP made up 0.8% of Wall Street Associates's portfolio in Q4 2016, its #41 holding.
  • Wall Street Associates first reported a position in NEOPHOTONICS CORP in Q4 2015 and has held it in 5 quarters since.
  • Wall Street Associates's NEOPHOTONICS CORP position peaked at $2.9M in Q3 2016.
  • 127 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.